Other

Updated:

Churchill Capital Corp XII

Churchill Capital Corp XII is a $2 billion SPAC led by Michael Klein.

Churchill Capital Corp XII

Churchill Capital Corp XII is a special purpose acquisition company led by financier Michael Klein. The SPAC was formed in 2022 and raised $2 billion in its IPO in December of that year (per SEC filing, 2022). Klein, founder of investment bank M. Klein & Company, has become one of the most prolific SPAC sponsors on Wall Street. Per public filings, Churchill Capital Corp XII seeks to acquire a business in the technology, media, sustainability, or healthcare industries. The SPAC's investment mandate includes companies with enterprise values of $2 billion or more. Klein's previous Churchill Capital transactions include the 2020 merger with Skillsoft and the 2021 business combination with Lucid Diagnostics. The geographic scope is primarily North America. The vehicle holds $2 billion in trust and is Klein's 12th Churchill Capital SPAC. The team behind the SPAC includes M. Klein & Company professionals and outside advisors. As of mid-2024, no business combination had been announced. Other Churchill entities have included Churchill Capital Corp V, which merged with Sonder Holdings in 2021. The structural differentiator is the pure SPAC model: Churchill Capital Corp XII is a blank-check company with no operating assets beyond its trust, existing solely to identify and complete a merger. Klein's serial approach — raising multiple SPACs over a decade — is unusual in scale and reflects an institutionalized SPAC origination process.

General information

Firm type

Other

Year founded

2022

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, New York, United States

Principals

Michael Klein

Chairman and Chief Executive Officer

Sector focus

Special Purpose Acquisition Company

Frequently asked questions

Who leads investment decisions at Churchill Capital Corp XII?

Michael Klein serves as Chairman and Chief Executive Officer of the SPAC. He founded M. Klein & Company and has sponsored over a dozen Churchill Capital SPACs since 2015 (per SEC filings).

What is the investment target for Churchill Capital Corp XII?

The SPAC seeks to acquire a business in the technology, media, sustainability, or healthcare industries, with a focus on companies with enterprise values of $2 billion or more (per the firm's IPO prospectus, 2022).

How does Churchill Capital Corp XII source deals?

Deal sourcing is managed by Michael Klein and his team at M. Klein & Company, leveraging relationships built over decades in investment banking. The SPAC typically targets businesses with strong growth profiles in North America.

What is the SPAC's time frame to complete a merger?

Churchill Capital Corp XII has a typical 24-month window from its December 2022 IPO to complete a business combination, with possible extensions per its charter (per SEC filings). As of mid-2024, no deal had been announced.

How does Churchill Capital Corp XII relate to other Churchill Capital SPACs?

It is the 12th in a series of SPACs sponsored by Michael Klein. Previous Churchill entities include Churchill Capital Corp V (which merged with Sonder Holdings), Churchill Capital Corp VII (Skillsoft), and others.

What is Michael Klein's track record with SPACs?

Klein has been a leading SPAC sponsor since 2015, completing mergers with companies like Skillsoft, Lucid Diagnostics, and Sonder Holdings. His success rate and market reputation make him a prominent figure in the blank-check space (per Bloomberg, 2021).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More New York Other profiles